Literature DB >> 8592904

Comparative in vitro activity of 11 beta-lactam antibiotics against 91 Staphylococcus intermedius strains isolated from staphylococcal dermatitis in dogs.

S Piriz1, R de la Fuente, J Valle, E Mateos, M A Hurtado, D Cid, J A Ruiz-Santaquiteria, S Vadillo.   

Abstract

A study was made of the susceptibility of 91 strains of Staphylococcus intermedius, isolated from staphylococcal dermatitis of dogs, to 11 beta-lactam antimicrobial agents. The activity of these antimicrobial agents against all strains was tested at pH 7.2 and 8.5. Finally, a comparative study was made of the susceptibility of these micro-organisms, dividing them into six groups: beta-lactamase positive and negative, methicillin resistant and susceptible and oxacillin resistant and susceptible. Only three of the 11 antimicrobial agents studied exhibited satisfactory behaviour at the two pH levels studied: mezlocillin, cefazolin and cefalotine. There was a good correlation at pH 8.5 between methicillin-resistant strains and those resistant to penicillin G, ampicillin, amoxycillin, cefamandole and cefuroxime. This correlation was not observed, however, between oxacillin-resistant strains and strains resistant to the other antimicrobial agents studied.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8592904     DOI: 10.1111/j.1439-0450.1995.tb00713.x

Source DB:  PubMed          Journal:  Zentralbl Veterinarmed B        ISSN: 0514-7166


  2 in total

1.  Direct Repeat Unit (dru) Typing of Methicillin-Resistant Staphylococcus pseudintermedius from Dogs and Cats.

Authors:  Kristina Kadlec; Stefan Schwarz; Richard V Goering; J Scott Weese
Journal:  J Clin Microbiol       Date:  2015-09-16       Impact factor: 5.948

2.  Comparative genomics of the Staphylococcus intermedius group of animal pathogens.

Authors:  Nouri L Ben Zakour; Scott A Beatson; Adri H M van den Broek; Keith L Thoday; J Ross Fitzgerald
Journal:  Front Cell Infect Microbiol       Date:  2012-04-18       Impact factor: 5.293

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.